SRCM
MRNA icon

Signature Resources Capital Management’s Moderna MRNA Stock Holding History

Signature Resources Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29K Buy
47
+15
+47% +$776 ﹤0.01% 482
2026
Q1 		$1.63K Hold
32
– – ﹤0.01% 549
2025
Q4 		$944 Hold
32
– – ﹤0.01% 558
2025
Q3 		$827 Hold
32
– – ﹤0.01% 479
2025
Q2 		$883 Hold
32
– – ﹤0.01% 481
2025
Q1 		$907 Hold
32
– – ﹤0.01% 343
2024
Q4 		$1.33K Hold
32
– – ﹤0.01% 325
2024
Q3 		$2.14K Hold
32
– – ﹤0.01% 301
2024
Q2 		$3.8K Hold
32
– – ﹤0.01% 283
2024
Q1 		$3.18K Hold
32
– – ﹤0.01% 287
2023
Q4 		$3.18K Buy
+32
New +$2.69K ﹤0.01% 288

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Signature Resources Capital Management's MRNA Position: Q2 2026 in Review

Signature Resources Capital Management increased its Moderna (MRNA) stake by 47% in Q2 2026, buying an estimated $776 and bringing the position to 47 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

Signature Resources Capital Management first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.8K in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Signature Resources Capital Management held 47 shares of Moderna worth $3.29K as of Q2 2026.
  • Signature Resources Capital Management bought 15 Moderna shares in Q2 2026, an estimated $776.
  • Moderna made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #482 holding.
  • Signature Resources Capital Management first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • Signature Resources Capital Management's Moderna position peaked at $3.8K in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.